Pharmacotherapy in Adults With ADHD
1997; Slack Incorporated (United States); Volume: 27; Issue: 8 Linguagem: Inglês
10.3928/0048-5713-19970801-07
ISSN1938-2456
AutoresAmar N. Bhandary, Francisco Arnalich, Robert J. Gregory, Phebe Tucker, Prakash S. Masand,
Tópico(s)Pharmaceutical studies and practices
ResumoATTENTION DEFICIT HYPERACTIVITY DISORDER IN ADULTHOODPharmacotherapy in Adults With ADHD Amar N Bhandary, MD, , , MD Francisco Fernandez, MD, , , MD Robert J Gregory, MD, , , MD Phebe Tucker, MD, , and , MD Prakash Masand, MD, , MD Amar N Bhandary, MD , Francisco Fernandez, MD , Robert J Gregory, MD , Phebe Tucker, MD , and Prakash Masand, MD Published OnlineAugust 01, 1997https://doi.org/10.3928/0048-5713-19970801-07PDFView Full Text ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail SectionsMore1. Bellak L, Black RB. Attention deficit hyperactivity disorder in adults. Clin Then 1992; 14:138-147. Google Scholar2. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: American Psychiatric Press; 1994:78-85. Google Scholar3. Weiss G, Hechtmann L, Milroy T, et al. Psychiatric status of hyperactives as adults: a controlled fifteen year followup of sixty-three hyperactive children. J Am Acad Child Psychiatry. 1985;24:211-223. Google Scholar4. Denckla MB. Attention deficit hyperactivity disorder residual type. J Child Neurol. 1991; 6(suppl):S44-S50. Google Scholar5. Hunt RD, Mandi L, Lau S, et al. Neurobiologica] theories of ADHD. In: Greenhill LL, Osman BB, eds. Ritalin: Theory and Patient Management. New York, NY: Mary Ann Liebert Inc; 1991:267-288. Google Scholar6. Chelune GJ, Ferguson W, Koon R, et al. Frontal lobe disinhibition in attention deficit disorder. Child Psychiatry Hum Dev. 1986; 16:221-234. Google Scholar7. Bhandary AN, Gregory RJ, Carmen L, et al. Psychostimulants and beta blockers; combination pharmacotherapy for attention deficit hyperactivity disorder. Annual meeting American Psychiatric Association; Miami, Fla; May 22, 1995. Google Scholar8. Ratey JJ, Greenburg MS, Lindem KJ. Combination of treatments for attention deficit hyperactivity disorder in adults. J Nerv Ment Dis. 1991; 179:699-701. Google Scholar9. Anderson GM. Reviewing the role of serotonin in disruptive behaviors. J Child Adolesc Psychoph, 1993; 3:vii-ix. Google Scholar10. Bradley C. The behavior of children receiving benzedrine. Am J Psychiatry. 1937; 94:577-585. Google Scholar11. Hill D. Amphetamine in psychopathic states. Brit J Addictions. 1947; 44:50-54. Google Scholar12. Arnold LD, Strobl D, Weisenberg A. A hyperkinetic adult: study of the paradoxical amphetamine response. JAMA. 1972; 222:693-694. Google Scholar13. Gomez RL, Janowsky D, Zeitin M, et al. Adult psychiatric diagnosis and symptoms compatible with the hyperactive child syndrome: a retrospective study. J Clin Psychiatry. 1981; 42:389-394. Google Scholar14. Shekim WO, Asarnow RF, Hess E, et al. The clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder residual state. Compr Psychiatry. 1990; 31:416-425. Google Scholar15. Bhandary AN. The adulthood syndrome of attention deficit hyperactivity disorder. J Pract Psych Beh Health. In press. Google Scholar16. Wender PH. Attention Deficit Disorder in Adults. New York, NY: Oxford University Press; 1995:144-197. Google Scholar17. Green WH. Non-stimulant drugs in treatment of attention deficit hyperactivity disorder in children and adolescents. Psychiatr Clin North Am. 1992; 2:449-465. Google Scholar18. Hunt H, Lau S, Ryu J. Alternative therapies for ADHD. In: Osman BB, Greenhill LL, eds. Ritalin: Theory and Patient Management. New York, NY: Mary Ann Liebert; 1991:75-96. Google Scholar19. Wilens TD, Spencer TJ, Biederman M. Pharmacotherapy of adult attention deficit hyperactivity disorder. Progress Notes; American Society of Clinical Psychopharmacology. 1994; 5:1-4. Google Scholar20. Greenhill LL. Attention deficit hyperactivity disorder; the stimulants. Child Adolesc Psych Clin North Am. 1995;4:123-168. Google Scholar21. Wilens TE, Biederman J. The stimulants. Psychiatr Clin North Am. 1992;15:191-122. Google Scholar22. Wood DR, Reimherr FW, Wender PH, et al. Diagnosis and treatment of minimal brain dysfunction in adults. Arch Gen Psychiatry. 1976; 33;1453-1460. Google Scholar23. Wender PH, Reimherr FW, Wood D, et al. A controlled study of methylphenidate in the treatment of attention deficit disorder residual type in adults. Am J Psychiatry. 1985; 142:547-552. Google Scholar24. Mattes JA, Boswell L, Oliver H. Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry. 1984; 41:1059-1063. Google Scholar25. Gualtieri CT, Ondrusek MG, Finley C. Attention deficit disorder in adults. Clin Neuropharmacol. 1985; 8:343-356. Google Scholar26. Spencer T, Wilens TE, Biederman J, et al. A double blind comparison of methylphenidate and placebo in adults with adult deficit hyperactivity disorder. Arch Gen Psychiatry. 1995; 52:350-353. Google Scholar27. Wender PH, Reimherr FW, Wood DR. Attention deficit disorder ('minimal brain dysfunction') in adults: a replication study of diagnosis and drug treatment. Arch Gen Psychiatry. 1981; 38:449-456. Google Scholar28. Caresia L, Pugnetti L, Bessana R, et al. EEG and clinical findings during pemoline treatment in children and adults with adult deficit disorder; an 8 week open trial. Neuropsychobiology. 1984; 11:158-167. Google Scholar29. Clinical use of methamphetamine in attention deficit disorder (ADD). Abbott Park, ??: Abbott Laboratories; 1994. Google Scholar30. Chiarello RJ, Cole JO. The use of psychostimulants in general psychiatry, a consideration. Arch Gen Psychiatry. 1981; 38:449-456. Google Scholar31. Sprague RL, Sleator EK. Methylphenidate in hyperactive children: differences in dose effects on learning and social behaviors. Science. 1977; 38:1274-1276. Google Scholar32. Physician's Desk Reference. 50th ed. Oradell, NJ: Medical Economics; 1996. Google Scholar33. Barkley RA, Du Paul GJ, McMurray MB, et al. Attention deficit disorder with and without hyperactivity; clinical response to three dose levels of methylphenidate. Pediatrics. 1991; 87:519-531. Google Scholar34. Ratey JJ, Hallowell E, Leveroni CL. Pharmacotherapy for ADHD in adults. Adult Attention Deficit Disorder Conference; Ann Arbor, Mich; May 1994. Google Scholar35. Gualtieri CT. Neuropsychiatry and Behavior Pharmacology. Berlin: Springer-Verlag; 1990:37-89. Google Scholar36. Robinson DR, Bailine S, Alvir J, et al. Pharmacological responses to psychostimulants in borderline and schizotypal personality disorders. Annual Meeting American College of Neuropsychopharmacology; 1989. Google Scholar37. Elia J, Rappoport JL. Ritahn versus dextro-amphetamine in ADHD: should both be tried. In: Greenhill LL, Osman BB, eds. Ritalin: Theory and Patient Management. New York, NY: Mary Ann Liebert Inc; 1991:69-74. Google Scholar38. Werry JS. Pharmacotherapy of disruptive behavior disorders. Child Adolesc Psychiatr Clin North Am. 1994; 3:321-341. Google Scholar39. Ratey JJ, Greenberg MS, Bemporad JR, et al. Unrecognized attention deficit hyperactivity disorder in adults presenting for outpatient psychotherapy. J Child Adolesc Psychopharmacology. 1992; 2;267-275. Google Scholar40. Schatzberg AF, Nemeroff CB. Textbook of Psychopharmacology. 1st ed. Washington, DC: American Psychiatric Press; 1995. Google Scholar41. Rapoport MD, Carlson CA Kelly KL, et al. Methylphenidate and desipramine in ADHD children, I: separate and combined effects on cognitive functions. J Am Acad Child Adolesc Psychiatry. 1993; 32:333-342. Google Scholar42. Wilens TE, Biederman J, Mick E, et al- A systemic assessment of tricyclic antidepressants in the treatment of adult attention deficit hyperactivity disorder. J Nerv Ment Disord. 1995; 183:48-50. Google Scholar43. Rapoport J Childhood behavior and learning problems treated with Imipramine. Int J Neurosci. 1965; :635-642. Google Scholar44. Huessey HR. Imipramine in attention deficit disorder. Am J Psychiatry. 1983; 140:272. Google Scholar45. Wilens TE, Price J, Spencer T, et al. Six week double blind placebo-controDed study of desipramine in adult attention deficit hyperactivity disorder: preliminary results. Am J Psychiatry. 1996; 153:1147-1153. Google Scholar46. Wender PH, Reimherr RW. Buproprion treatment of attention deficit disorder ('minimal brain dysfunction') in adults. Am J Psychiatry. 1990; 147:1018-1023. Google Scholar47. Simeon JG, Ferguson HB, Van Wyck Fleet J. Buproprion effects in attention deficit and conduct disorders. Can J Psychiatry. 1986; 31:581-585. Google Scholar48. Wolfe KD, Weiler EB, Weller RA, et al. Treating children with attention deficit hyperactivity disorder; a douhle blind buproprion trial. Annual Meeting American Academy of Child and Adolescent Psychiatry; San Antonio, Tex; 1993. Google Scholar49. Hedges DW, Reimherr FW, Roger A, et al. An open trial of Venlafaxine in adult patients with attention deficit hyperactivity disorder. Psychopharmacol Bull. 1995; 31:779-783. Google Scholar50. Adler LA, Resnick S, Kunz M, et al. Open label trial of venlafaxine in adults with attention deficit disorder. Psychopharmacol Bull. 1995; 31:785-788. Google Scholar51. Zubieta JK, Alessi NE. Acute and chronic administration of trazodone in the treatment of disruptive behavior disorders in childhood. J Clin Psychopharmacol. 1992; 12:346-351. Google Scholar52. Shekim WO, Maaterson A, Cantwell DP, et al. Nomifensine maleate in adult attention deficit disorder. J Nerv Ment Disord. 1989; 177:296-299. Google Scholar53. Barrickman L, Noyes R, Kuperman S, et al. Treatment of attention deficit hyperactivity disorder with fluoxetine; a preliminary trial. J Am Acad Child Adolesc Psychiatry. 1991; 30:762-767. Google Scholar54. Gammons GD, Brown TE. Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder. J Child Adolesc Psychopharmacology. 1993; 3:1-10. Google Scholar55. Bussing R, Levin GM. Methamphetamine and fluoxetine treatment of a child with attention deficit hyperactivity disorder and obsessive compulsive disorder. J Child Adolesc Psychopharmacology. 1993; 3:53-58. Google Scholar56. Bhandary AN, Masand PS, Gregory RJ. Obsessive compulsive disorder; combination pharmacotherapy with SSRI and psychostimulants. Annual meeting American Academy of Clinical Psychiatry; San Diego, Calif; October 22, 1995. Google Scholar57. Zametkin AJ, Rapoport JL, Murphy DL1 et al. The treatment of hyperactive children with monoamine oxidase inhibitors. Arch Gen Psychiatry. 1985; 42:962-966. Google Scholar58. Wender PH, Wood D, Reimherr FW, et al. An open trial of pargyline the treatment of attention deficit disorder residual type in adults. Psychiatry Res. 1983; 9:329-336. Google Scholar59. Wood DR, Reimherr FW, Wender PH, et al. The use of LDeprynyl in the treatment of attention deficit disorder residual type (ADD-RT). Psychopharmacol Bull. 1983; 19:627-629. Google Scholar60. Trott GE, Friese HJ, Menzel M, et al. Use of moclobemide in children with attention deficit hyperactivity disorder. Psychopharmacology (Beri). 1992; 106(suppl):134-136. Google Scholar61. Hunt RD. Guanfacine in attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1995; 34:50-54. Google Scholar62. Mattes J. Propranalol for adults with temper outbursts and residual attention deficit disorder. J Clin Psychopharmacol. 1986; 6:299-302. Google Scholar63. Bhandary AN, Masand PS. Buspirone in the management of disruptive behaviors. Psychosomatics. In press. Google Scholar64. Balon R. Buspirone for attention deficit hyperactivity disorder. J Clin Psychiatry. 1990; 10:77. Letter. Google Scholar65. Quaison N, Ward D, Kitchen T. Buspirone for aggression. J Am Acad Child Adolesc Psychiatry. 1991; 30:1026. Letter. 66. Google Scholar66. Mitchell WG, Zhou Y, Chavez JM, et al. Effects of antiepileptic drugs on reaction time attention and impulsivity in children. Pediatrics. 1993; 91:101-105. Google Scholar67. Bhandary AN, Fernandez F, Gregory RJ. Treatment strategies in the pharmacological management of adults with attention deficit hyperactivity disorder. Annual meeting of the Institute of Psychiatric Services; Boston, Mass; October 4, 1995. Google Scholar68. Gittleman-Klein R. Childhood disorders. In: Klein D, Quitkin F, Rifkin A, eds. Drug Treatment of Adulthood and Childhood Psychiatric Disorders. Baltimore, Md: Williams & Wilkins; 1980:576-756. Google Scholar69. Shekim WO, Autun F, Hanna GL, et al. S-adenosyl methionine (SAM) in adults with attention deficit hyperactivity disorder-residual type. Psychopharmacol Bull. 1990; 26:249-253. Google Scholar70. Nemzer ED, Arnold LE, Votolato NA, et al. Amino acid plementation as therapy for attention deficit disorder. J Am Acad Child Adolesc Psychiatry. 1986; 25:509-513. Google Scholar71. Cocorea JA, Danes RK, Mueller PS, et al. Cocaine and adult attention deficit disorder. J Child Psychiatry. 1987; 48:376-377. Google Scholar72. Reimherr FW, Wood D, Wender PH. An open clinical trial L-Dopa and carbidopa in adults with minimal brain function. Am J Psychiatry. 1980; 137:73-75. Google Scholar73. Defined diets and childhood hyperactivity. Consensus development conference; National Institute of Health; Bethesda, Md; 1982. Google Scholar74. Weiss RD, Pope HG, Mirin SM. Treatment of cocaine abuse and attention deficit disorder, residual type with magnesium pemoline. Drug Alcohol Depend. 1985; 15:69-72. Google Scholar75. Bhandary AN, Pfefferbaum B. Pharmacotherapeutic management of primary nonresponder adults with attention deficit hyperactivity disorder. Annual meeting of the Institute of Psychiatric Services; Chicago, 111; October 1996. Google Scholar Previous article Next article FiguresReferencesRelatedDetails Request Permissions InformationCopyright 2013, SLACK IncorporatedPDF download
Referência(s)